These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Papaverine-induced priapism: case report. Liu LH; Liu LC; Huang CH; Chiang CP Gaoxiong Yi Xue Ke Xue Za Zhi; 1987 Oct; 3(10):682-3. PubMed ID: 3482263 [No Abstract] [Full Text] [Related]
3. [Priapism as a complication following diagnostic papaverine test]. Darewicz J; Galek L Z Urol Nephrol; 1989 Jun; 82(6):317-9. PubMed ID: 2763728 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological priapism: comparison of trazodone- and papaverine-associated cases. Bardin ED; Krieger JN Int Urol Nephrol; 1990; 22(2):147-52. PubMed ID: 2354895 [TBL] [Abstract][Full Text] [Related]
5. [Prolonged erections after diagnostic injection of papaverine chlorhydrate]. Rajmil O; García F; Fabián E; Bassas L; Pomerol JM Arch Esp Urol; 1991 Mar; 44(2):179-82. PubMed ID: 1867493 [TBL] [Abstract][Full Text] [Related]
6. Nocturnal computed rigidity and tumescence evaluation in the prevention of the iatrogenic priapism. Quadraccia A; Salvini A; Cordani C; Pizzi P; Bellinzoni G Acta Urol Belg; 1988; 56(2):226-31. PubMed ID: 3400529 [No Abstract] [Full Text] [Related]
7. Induced priapism and its management. Török A; Jilling A; Götz F Int Urol Nephrol; 1991; 23(2):191-4. PubMed ID: 1864717 [TBL] [Abstract][Full Text] [Related]
8. [Priapism as a complication of the treatment of impotence by local injections of papaverine]. Kaczmarek A Wiad Lek; 1990 Sep 1-15; 43(17-18):908-10. PubMed ID: 2278150 [TBL] [Abstract][Full Text] [Related]
9. The incidence of pharmacologically induced priapism in the diagnostic and therapeutic management of 685 men with erectile dysfunction. Perimenis P; Athanasopoulos A; Geramoutsos I; Barbalias G Urol Int; 2001; 66(1):27-9. PubMed ID: 11150947 [TBL] [Abstract][Full Text] [Related]
10. Heterotopic bone formation in the corpus cavernosum: a complication of papaverine-induced priapism. Vapnek J; Lue TF J Urol; 1989 Nov; 142(5):1323-4. PubMed ID: 2509734 [TBL] [Abstract][Full Text] [Related]
16. [The intracavernosal administration of papaverine in the diagnosis and treatment of sexual disorders in men]. Gorpinchenko II; Khudaĭberdiev NA Vrach Delo; 1989 Oct; (10):102-5. PubMed ID: 2617964 [TBL] [Abstract][Full Text] [Related]
17. [Priapism following intracavernous injection of vasoactive substances as a urologic emergency]. Papadopoulos I; Weichert-Jacobsen K; Wand H Z Urol Nephrol; 1990 May; 83(5):233-7. PubMed ID: 2392883 [TBL] [Abstract][Full Text] [Related]
18. Priapism associated with concurrent use of phosphodiesterase inhibitor drugs and intracavernous injection therapy. McMahon CG Int J Impot Res; 2003 Oct; 15(5):383-4. PubMed ID: 14562142 [No Abstract] [Full Text] [Related]
19. [Diagnostic intracorporeal papaverine injection]. Liu LH Gaoxiong Yi Xue Ke Xue Za Zhi; 1988 Feb; 4(2):99-102. PubMed ID: 3163017 [No Abstract] [Full Text] [Related]
20. [Are intracavernous injections of drugs for impotence harmless?]. Bondil P Acta Urol Belg; 1988; 56(2):202-10. PubMed ID: 3400526 [No Abstract] [Full Text] [Related] [Next] [New Search]